Corran Normann Mclachlan

Title: Corran Normann Mclachlan: Innovator in Dietary Supplements

Introduction

Corran Normann Mclachlan is a notable inventor based in New Zealand. He has made significant contributions to the field of dietary supplements, particularly focusing on the therapeutic uses of .beta.-casein A2. His innovative approach aims to improve health outcomes related to cholesterol levels in mammals.

Latest Patents

Corran holds a patent titled "Therapeutic Uses Of .beta.-Casein A2 And Dietary Supplement Containing .beta.-Casein A2." This patent describes a method for reducing serum levels of various cholesterol types, including low-density lipoprotein (LDL) cholesterol, relative to high-density lipoprotein (HDL) cholesterol. The method involves the ingestion of a composition containing .beta.-casein A2, which is comprised of at least 95% .beta.-casein A2. This dietary supplement can be added to food or drink for human consumption.

Career Highlights

Corran is associated with A2 Corporation Limited, a company that focuses on dairy products containing A2 beta-casein. His work has contributed to the understanding of how specific dietary components can influence health, particularly in relation to cholesterol management.

Collaborations

Some of Corran's coworkers include Julie Hazel Campbell and Kristy Ann Tailford. Their collaborative efforts contribute to the innovative research and development at A2 Corporation Limited.

Conclusion

Corran Normann Mclachlan is a dedicated inventor whose work in dietary supplements has the potential to impact health positively. His focus on .beta.-casein A2 highlights the importance of specific dietary components in managing cholesterol levels.